Connor Clark and Lunn Investment Management Ltd. purchased a new position in shares of Arbutus Bioph

Bank of America Corp DE lowered its stake in Arbutus Biopharma Corporation (NASDAQ: ABUS) by 8.1% du

WARMINSTER, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Ar

Arbutus Biopharma (ABUS) stock rises after announcing a $230M stock buyback via a modified Dutch auc

Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical

WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Ar

Arbutus Biopharma (NASDAQ: ABUS - Get Free Report) and YD Bio (NASDAQ: YDES - Get Free Report) are b

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.03) per share which missed the anal

Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the launch of Invenia™ ABUS (Automated Breas

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce

Arbutus Biopharma is now much better capitalized after Moderna validated the value of its LNP patent

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly earnings of $0.87 per share which beat the analys

Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation s

Moderna stock rises after EU approval of flu-COVID combo vaccine mCOMBRIAX, backed by Phase 3 data s

U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopha

J B Hunt Transport Services Inc (JBHT) stock rose in pre-market trading after beating earnings estim

Arbutus Biopharma Corporation (Nasdaq: ABUS) ("Arbutus" or the "Company"), a clinica

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdu

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.01) per share which beat the analys

Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of Dece

Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor c

Box Inc (BOX) shares jump 6.2% in pre-market trading after beating earnings expectations with $305

The company will appeal to a federal circuit court to argue that it has limited liability due to its

Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust l

Moderna to pay $950 million with no future royalties to resolve all global litigation; corresponding

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent u

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent u

Arbutus Biotech faces a pivotal March jury trial against Moderna over LNP patent infringement, creat

Arbutus (ABUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the com

Strong financial position with cash, cash equivalents and marketable securities of $93.7M     Modern

Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a poten

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report

  During Thursday, 849 stocks hit new 52-week lows.

  Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly ea

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e

Gainers

Gainers

  Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q